Singulex receives award for North American Technology Innovation

2009-May-29

The 2009 North American Frost & Sullivan Technology Innovation Award in the field of Immunoassay Technologies for Biomarker Detection is presented to Singulex, Inc. for pioneering an immunoassay system capable of quantifying biomarkers at or below the subpicogram per mL concentrations. Known as the Erenna® Immunoassay System, it promises to assist drug developers in testing drug efficacy and drug safety parameters while also aiding physicians to monitor disease progression.

Read full award details here.